Association between posterior cerebral artery involvement and arterial wall enhancement in moyamoya disease: a cross-sectional study with vessel wall imaging
Authors:
- 15 May 2026
- journal article
- Published by Springer Nature in Neuroradiology
- Vol. 68 (9) , 2613-2621
Abstract
Early detection and activity assessment of posterior cerebral artery (PCA) involvement in moyamoya disease (MMD) are challenging. We aimed to assess the cross-sectional association between PCA involvement and PCA wall enhancement on vessel wall MRI (DANTE T1-SPACE). We analyzed consecutive patients with MMD who underwent both non-contrast-enhanced and contrast-enhanced DANTE T1-SPACE. Positive wall enhancement was defined as location-appropriate arterial wall enhancement with an enhancement ratio ≥ 1.5. PCA involvement was graded 0-2 on MRA obtained during the same period. Of 368 hemispheres from 184 patients, 56 (15.2%) showed PCA involvement and 17 (4.6%) showed PCA wall enhancement. PCA involvement was present in 94.1% of enhancement-positive hemispheres versus 11.4% of enhancement-negative hemispheres (p < 0.001). The difference was consistent across age, Suzuki stage, and RNF213 genotype strata. Enhancement most often involved the P2A segment. Topographical correspondence between enhancement and the stenoocclusive lesion was excellent (overall percent agreement, 94.1%). PCA wall enhancement was observed in 0.3%, 61.5%, and 18.6% of hemispheres with grade 0, 1, and 2 PCA involvement, respectively. Positive enhancement was more frequent in grade 1 PCA involvement than in grade 2 (adjusted p = 0.02). Statistical and topographical findings suggest a strong cross-sectional association between PCA involvement and PCA wall enhancement. The enhancement may be associated with disease activity and may facilitate detection of early-stage PCA involvement with high specificity; these hypotheses require confirmation in longitudinal cohorts.Keywords
This publication has 36 references indexed in Scilit:
- Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan studyJournal of Stroke and Cerebrovascular Diseases, 2023
- Vessel wall MRI in moyamoya disease: arterial wall enhancement varies depending on age, arteries, and disease progressionEuropean Radiology, 2023
- Vessel wall enhancement as a predictor of arterial stenosis progression and poor outcomes in moyamoya diseaseEuropean Radiology, 2022
- Joint intracranial and carotid vessel wall imaging in 5 minutes using compressed sensing accelerated DANTE-SPACEEuropean Radiology, 2019
- Stenosis Severity-Dependent Shrinkage of Posterior Cerebral Artery in Moyamoya DiseaseWorld Neurosurgery, 2019
- Prediction of Intracranial Arterial Stenosis Progression in Patients with Moyamoya Vasculopathy: Contrast-Enhanced High-Resolution Magnetic Resonance Vessel Wall ImagingWorld Neurosurgery, 2018
- T2‐Weighted intracranial vessel wall imaging at 7 Tesla using a DANTE‐prepared variable flip angle turbo spin echo readout (DANTE‐SPACE)Magnetic Resonance in Medicine, 2016
- Improved black‐blood imaging using DANTE‐SPACE for simultaneous carotid and intracranial vessel wall evaluationMagnetic Resonance in Medicine, 2015
- Joint blood and cerebrospinal fluid suppression for intracranial vessel wall MRIMagnetic Resonance in Medicine, 2015
- DANTE‐prepared pulse trains: A novel approach to motion‐sensitized and motion‐suppressed quantitative magnetic resonance imagingMagnetic Resonance in Medicine, 2012